Voyager Therapeutics, Inc.
VYGR • NASDAQ
Voyager Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Alfred W. Sandrock Jr., with a market cap of $236.0M.
Market Cap$236.0M
Employees162.0
CEOAlfred W. Sandrock Jr.
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 5, 2026 · In 3 weeksQ1 2026
Financials
Voyager Therapeutics, Inc. FAQ
Common questions about Voyager Therapeutics, Inc.
Voyager Therapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 5, 2026. Analysts estimate revenue of $8.9M.
Voyager Therapeutics, Inc. has approximately 162 employees.